denali therapeutics stock price
Monitor SEC Form 4 Insider Trading Filings for Insider Buying and Selling. Denali Therapeutics Inc.
DNLI came out with a quarterly loss of 062 per share versus the Zacks Consensus Estimate of a loss of 041.
. Real-time Insider Trading Stock Screener. This compares to earnings of 191 per share a year ago. Long and Short Trading Ideas using Insider Transaction Data.
Denali Therapeutics Share Price Dnli Stock Quote Charts Trade History Share Chat Financials Denali Therapeutics Inc
Related
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
The Goldman Sachs Group Cuts Denali Therapeutics Nasdaq Dnli Price Target To 98 00 Marketbeat
Denali Therapeutics Nasdaq Dnli Shareholder Returns Have Been Stellar Earning 206 In 3 Years Nasdaq
Ideas And Forecasts On Denali Therapeutics Inc Nasdaq Dnli Tradingview
Denali Therapeutics Share Price Dnli Stock Quote Charts Trade History Share Chat Financials Denali Therapeutics Inc
Denali Therapeutics Inc Dnli Stock Price News Info The Motley Fool
Denali Therapeutics Inc Dnli Stock Price News Info The Motley Fool
Denali Therapeutics Market Makers See As Underpriced Nasdaq Dnli Seeking Alpha
Denali Therapeutics Inc 4dn Stock Price Us24823r1059 Marketscreener
Dnli Stock Price And Chart Nasdaq Dnli Tradingview
Denali Therapeutics Share Price Dnli Stock Quote Charts Trade History Share Chat Financials Denali Therapeutics Inc
Denali Inks Collab With Takeda To Help Alzheimer S Drugs Get Into The Brain Massdevice
Denali Therapeutics Announces Pricing Of Initial Public
Denali Dnli Q4 Loss Wider Than Expected Revenues Lag
Denali Therapeutics Market Makers See As Underpriced Nasdaq Dnli Seeking Alpha
Goldman Sachs 2 Stocks That Could Climb Over 90 Nasdaq
Denali Therapeutics Inc Dnli Moves 7 5 Higher Will This Strength Last
Denali Therapeutics Inc S Nasdaq Dnli Fundamentals Look Pretty Strong Could The Market Be Wrong About The Stock Nasdaq
